Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Want to earn the most credit card points? Explore effective strategies to boost your rewards and make the most of your spending.
22,876 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Cardano’s ADA has traded in a tight range around $0.29-$0.30 for 45 days. A sustained move above $0.30 with higher vo...
Ethereum surged about 8% over the past week, trading around $2,200 as traders weigh the next leg higher. On-chain sig...
Fresh data on unemployment filings show the labor market staying resilient. The big question remains whether the econ...
Investors chase $100,000 a year in dividend income, but the required capital hinges on yield and payout durability in...
Three global e-commerce leaders are trading at bargain prices as reinvestment cycles press on near‑term earnings, pot...
Lemonade stock surged about 16% this week thanks to a powerful mix of analyst optimism and progress in its AI-based u...
Investors weigh growth plans and political headlines as DJT faces a volatile path to profitability, with forecasts sp...
Volatility kept markets unsettled this week. Advisers say the right move depends on timelines and cash needs, with ma...
In San Francisco, activists and industry critics gathered outside AI hubs to demand a pause on fast-paced development...
As of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
A fresh analysis places the calendar of tax season squarely in the economic spotlight, revealing a $146 billion burde...